Medical
FDA Panel Backs Previously Rejected Obesity Pill
February 23, 2012 9:27 am | by Matthew Perrone, AP Health Writer | News | CommentsExperts agree new weight loss drugs are needed to treat an estimated 75 million obese adults in the U.S., but the FDA had thought some were not safe enough.
FDA: New Suppliers Ease Cancer Drug Shortages
February 21, 2012 1:01 pm | by Linda A. Johnson, AP Business Writer | News | CommentsRegulators said they've approved new suppliers for two crucial cancer drugs, but there are currently 283 other separate drugs in short supply.
J&J Recalls Infant Tylenol Over Bottle Confusion
February 17, 2012 10:56 am | by Linda A. Johnson, AP Business Writer | News | CommentsThe new infant bottle comes with a plastic syringe that's to be inserted into a flow restrictor for the correct dosage, but the restrictor often falls into the bottle.
FDA Raises Safety Concerns For Vivus Diet Pill
February 17, 2012 9:22 am | News | CommentsThe FDA had previously rejected the pill for potential heart problems and birth defects in women who become pregnant while taking the drug.
Counterfeit Drugs Becoming Big Business Worldwide
February 16, 2012 9:20 am | by Matthew Perrone, AP Health Writer | News | CommentsThe multibillion-dollar trade has largely been relegated to poor countries with lax regulations, but officials worry more counterfeits will be smuggled into America.
J&J: On Your Face, Not In It
February 15, 2012 12:21 pm | by Joel Hans, Managing Editor, Manufacturing.net | Blogs | CommentsJohnson and Johnson is becoming notorious for a long string of recalls and poor production practices, which leaves me wondering: How have they managed to avoid any genuine outcry?
Doctors Urge More Production Of Scarce Cancer Drug
February 14, 2012 9:29 am | by Linda A. Johnson, AP Business Writer | News | CommentsDoctors are panicking because methotexate is the key treatment for a common childhood cancer called acute lymphoblastic leukemia, and can cure 90 percent of cases.
FDA Shuts Down NJ Dental Products Company
February 13, 2012 1:43 pm | News | CommentsFederal health officials say Accurate Set has been legally barred from making and selling a variety of dental products due to violations at its manufacturing facility.
India's Global Pharmacy Role Threatened By EU Pact
February 10, 2012 9:33 am | by Katy Daigle, Associated Press | News | CommentsHealth industry workers worry India may bow to EU demands for strict IP protections, which would close down the supply of medicines to the world's poorest.
Funding Medical Device Innovation
February 8, 2012 9:24 am | by Rahul Sathe, Principal Mechanical Engineer, Surgical and Interventional Products, Cambridge Consultants | Articles | CommentsThe recent decline of venture financing is threatening innovation in the $300 billion global market for medical devices.
MRPC Expands Capabilities With New Class 100,000 Cleanroom
February 7, 2012 11:19 am | News | CommentsWisconsin-based MRPC, a single-source provider of medical device components and assemblies, has completed construction of a new cleanroom for the molding of medical components.
Smith & Nephew To Pay $22.2M For Greek Bribery
February 6, 2012 2:18 pm | by Marcy Gordon, AP Business Writer | News | CommentsThe British orthopedics maker was accused by the DOJ and SEC of bribing doctors employed by the Greek government for more than a decade to win business.
Drugmakers Singing Same Song: 2012 Will Be Tough
February 3, 2012 9:34 am | by Linda A. Johnson, AP Business Writer | News | CommentsBuzzwords such as "blockbuster" and "cash cow" have all but disappeared, and have been replaced "headwinds," ''austerity" and "efficiency."
Pakistan Closes Factory That Made Deadly Drugs
February 2, 2012 9:11 am | News | CommentsTests showed that tablets produced in the facility contained massive doses of anti-malarial medicine that poisoned 100 heart patients.
Pfizer Profit Falls By Half Due To Generic Lipitor
January 31, 2012 9:19 am | News | CommentsCEO Ian Read said in a statement that patent losses, including that of Lipitor, cost the company $5 billion throughout 2011.
Gates Foundation, Drugmakers Push On Tropical Ills
January 30, 2012 2:04 pm | by Linda A. Johnson, AP Business Writer | News | CommentsThe government groups and charities alone are committing just over $785 million in new funding to protect more than a billion people.
Ex-Exec Charged For Faulty Breast Implants
January 27, 2012 1:21 pm | News | CommentsA judge placed Jean-Claude Mas, the founder and former chief of Poly Implant Prothese, under investigation for "involuntary injury."
Pfizer Sued In Puerto Rico Over Retirement Plans
January 27, 2012 9:27 am | by Ben Fox, Associated Press | News | CommentsThe suit alleges Pfizer allowed employees to amass such high concentrations of company stock that workers were extremely vulnerable to market fluctuations.
Caterpillar 4Q Profit Rises, Tops Wall St. View
January 26, 2012 2:35 pm | by Bree Fowler, AP Business Writer | News | CommentsThe world's largest maker of construction and mining equipment saw profit jump 60 percent, with a net income of $1.55 billion.
Ex-Head Of French Breast Implant Maker Arrested
January 26, 2012 9:38 am | by Jamey Keaten, Associated Press | News | CommentsJean-Claude Mas, who founded Poly Implant Prothese, was implicated in a cancer scandal affecting tens of thousands of women worldwide.
Abbott Cutting 700 Jobs
January 26, 2012 9:12 am | by Matthew Perrone, AP Health Writer | News | CommentsMedical device and drug maker Abbott Laboratories said it will lay off 700 employees as part of ongoing restructuring efforts.
Watson 2011 Earnings Jump On Generics
January 24, 2012 9:17 am | News | CommentsThe Parsippany, N.J., company said its generic versions of J&J and Pfizer medicines help its revenue jump 28 percent over 2010.
Pioneer Surgical Technology Announces The Expansion Of Biomanufacturing Facility
January 23, 2012 12:34 pm | News | CommentsPioneer Surgical Technology today announces the grand opening of its newly expanded Greenville manufacturing facility, which houses the primary manufacturing operations for products sold in the United States and Europe.
Novartis MS Drug Investigated After 11 Die
January 20, 2012 12:15 pm | News | CommentsThe drug, Gilenya, could trigger heart problems within 24 hours after patients take their first dose.
J&J Settles Texas Lawsuit For $158M
January 19, 2012 1:22 pm | by Jim Vertuno and Juan A. Lozano, Associated Press | News | CommentsThe company will pay for plundering the state Medicaid program by overstating the safety of an expensive anti-psychotic drug thanks to a whisleblower.
